Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Nasopharyngeal carcinoma (NPC) is a radiosensitive and chemosensitive tumor. This
randomized phase III trial compared concurrent chemoradiotherapy (CCRT) versus radiotherapy
(RT) alone in patients with advanced NPC.